Verve Therapeutics: Why I Am Exiting This Stock (NASDAQ:VERV)

News Room

My Verve Therapeutics (NASDAQ:VERV) thesis rests on the idea that while the clinical hold that the FDA put on VERV-101’s IND crushed the stock, the hold will be lifted in a limited number of months, which will see a quick

Read the full article here

Share this Article
Leave a comment